Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exelixis Inc (NASDAQ:EXEL)

23.59
Delayed Data
As of 4:00pm ET
 +0.24 / +1.03%
Today’s Change
10.04
Today|||52-Week Range
29.50
+58.22%
Year-to-Date
No recent news for Exelixis Inc.

Today’s Trading

Previous close23.35
Today’s open23.31
Day’s range23.18 - 23.97
Volume3,287,267
Average volume (3 months)4,055,092
Market cap$6.9B
Dividend yield--
Data as of 4:00pm ET, 09/26/2017

Growth & Valuation

Earnings growth (last year)+65.43%
Earnings growth (this year)+196.10%
Earnings growth (next 5 years)+46.00%
Revenue growth (last year)+415.05%
P/E ratio98.3
Price/Sales19.51
Price/Book75.79

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC+1.32+1.19%
CRLCharles River Labora...-0.41-0.39%
PRAHPRA Health Sciences ...-0.18-0.24%
PRXLPAREXEL Internationa...+0.03+0.04%
Data as of 4:02pm ET, 09/26/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)$0.08
Annual revenue (last year)$191.5M
Annual profit (last year)-$70.2M
Net profit margin-36.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Executive VP, Chief Financial &
Accounting Officer
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts